 | • レポートコード：GIR-105X13057 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、オシメルチニブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オシメルチニブの種類別市場規模（40mg * 30錠、80mg * 30錠、40mg * 10錠、80mg * 10錠）、用途別市場規模（局所進行NSCLC、転移性NSCLC、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オシメルチニブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、Incepta Pharmaceuticals Limited、Everest Pharmaceuticals、Beacon Pharma、Drug International ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：40mg * 30錠、80mg * 30錠、40mg * 10錠、80mg * 10錠 ・用途別分析2016年-2026年：局所進行NSCLC、転移性NSCLC、その他 ・オシメルチニブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オシメルチニブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オシメルチニブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オシメルチニブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オシメルチニブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Osimertinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Osimertinib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Osimertinib market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Osimertinib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
40mg*30 Tablets
80mg*30 Tablets
40mg*10 Tablets
80mg*10 Tablets
Market segment by Application can be divided into
Locally Advanced NSCLC
Metastatic NSCLC
Other
The key market players for global Osimertinib market are listed below:
AstraZeneca
Incepta Pharmaceuticals Limited
Everest Pharmaceuticals
Beacon Pharma
Drug International
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Osimertinib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Osimertinib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 40mg*30 Tablets
1.2.3 80mg*30 Tablets
1.2.4 40mg*10 Tablets
1.2.5 80mg*10 Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Osimertinib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Locally Advanced NSCLC
1.3.3 Metastatic NSCLC
1.3.4 Other
1.4 Global Osimertinib Market Size & Forecast
1.4.1 Global Osimertinib Sales in Value (2016-2026))
1.4.2 Global Osimertinib Sales in Volume (2016-2026)
1.4.3 Global Osimertinib Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Osimertinib Production Capacity Analysis
1.5.1 Global Osimertinib Total Production Capacity (2016-2026)
1.5.2 Global Osimertinib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Osimertinib Market Drivers
1.6.2 Osimertinib Market Restraints
1.6.3 Osimertinib Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Osimertinib Product and Services
2.1.4 AstraZeneca Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Incepta Pharmaceuticals Limited
2.2.1 Incepta Pharmaceuticals Limited Details
2.2.2 Incepta Pharmaceuticals Limited Major Business
2.2.3 Incepta Pharmaceuticals Limited Osimertinib Product and Services
2.2.4 Incepta Pharmaceuticals Limited Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Everest Pharmaceuticals
2.3.1 Everest Pharmaceuticals Details
2.3.2 Everest Pharmaceuticals Major Business
2.3.3 Everest Pharmaceuticals Osimertinib Product and Services
2.3.4 Everest Pharmaceuticals Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Beacon Pharma
2.4.1 Beacon Pharma Details
2.4.2 Beacon Pharma Major Business
2.4.3 Beacon Pharma Osimertinib Product and Services
2.4.4 Beacon Pharma Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Drug International
2.5.1 Drug International Details
2.5.2 Drug International Major Business
2.5.3 Drug International Osimertinib Product and Services
2.5.4 Drug International Osimertinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Osimertinib Sales by Manufacturer
3.1 Global Osimertinib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Osimertinib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Osimertinib
3.4 Market Concentration Rate
3.4.1 Top 3 Osimertinib Manufacturer Market Share
3.4.2 Top 6 Osimertinib Manufacturer Market Share
3.5 Global Osimertinib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Osimertinib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Osimertinib Market Size by Region
4.1.1 Global Osimertinib Sales in Volume by Region (2016-2026)
4.1.2 Global Osimertinib Revenue by Region (2016-2026)
4.2 North America Osimertinib Revenue (2016-2026)
4.3 Europe Osimertinib Revenue (2016-2026)
4.4 Asia-Pacific Osimertinib Revenue (2016-2026)
4.5 South America Osimertinib Revenue (2016-2026)
4.6 Middle East and Africa Osimertinib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Osimertinib Sales in Volume by Type (2016-2026)
5.2 Global Osimertinib Revenue by Type (2016-2026)
5.3 Global Osimertinib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Osimertinib Sales in Volume by Application (2016-2026)
6.2 Global Osimertinib Revenue by Application (2016-2026)
6.3 Global Osimertinib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Osimertinib Sales by Type (2016-2026)
7.2 North America Osimertinib Sales by Application (2016-2026)
7.3 North America Osimertinib Market Size by Country
7.3.1 North America Osimertinib Sales in Volume by Country (2016-2026)
7.3.2 North America Osimertinib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Osimertinib Sales by Type (2016-2026)
8.2 Europe Osimertinib Sales by Application (2016-2026)
8.3 Europe Osimertinib Market Size by Country
8.3.1 Europe Osimertinib Sales in Volume by Country (2016-2026)
8.3.2 Europe Osimertinib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Osimertinib Sales by Type (2016-2026)
9.2 Asia-Pacific Osimertinib Sales by Application (2016-2026)
9.3 Asia-Pacific Osimertinib Market Size by Region
9.3.1 Asia-Pacific Osimertinib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Osimertinib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Osimertinib Sales by Type (2016-2026)
10.2 South America Osimertinib Sales by Application (2016-2026)
10.3 South America Osimertinib Market Size by Country
10.3.1 South America Osimertinib Sales in Volume by Country (2016-2026)
10.3.2 South America Osimertinib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Osimertinib Sales by Type (2016-2026)
11.2 Middle East & Africa Osimertinib Sales by Application (2016-2026)
11.3 Middle East & Africa Osimertinib Market Size by Country
11.3.1 Middle East & Africa Osimertinib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Osimertinib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Osimertinib Typical Distributors
12.3 Osimertinib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Osimertinib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Osimertinib Revenue by Application, (USD Million), 2021-2026
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Osimertinib Product and Services
Table 6. AstraZeneca Osimertinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Incepta Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 8. Incepta Pharmaceuticals Limited Major Business
Table 9. Incepta Pharmaceuticals Limited Osimertinib Product and Services
Table 10. Incepta Pharmaceuticals Limited Osimertinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Everest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Everest Pharmaceuticals Major Business
Table 13. Everest Pharmaceuticals Osimertinib Product and Services
Table 14. Everest Pharmaceuticals Osimertinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Beacon Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Beacon Pharma Major Business
Table 17. Beacon Pharma Osimertinib Product and Services
Table 18. Beacon Pharma Osimertinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Drug International Basic Information, Manufacturing Base and Competitors
Table 20. Drug International Major Business
Table 21. Drug International Osimertinib Product and Services
Table 22. Drug International Osimertinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Osimertinib Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 24. Global Osimertinib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Osimertinib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Osimertinib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 27. Head Office and Osimertinib Production Site of Key Manufacturer
Table 28. Global Osimertinib Sales by Region (2016-2021e) & (K Pcs)
Table 29. Global Osimertinib Sales by Region (2021-2026) & (K Pcs)
Table 30. Global Osimertinib Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Osimertinib Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Osimertinib Sales by Type (2016-2021e) & (K Pcs)
Table 33. Global Osimertinib Sales by Type (2021-2026) & (K Pcs)
Table 34. Global Osimertinib Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Osimertinib Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Osimertinib Price by Type (2016-2021e) & (USD/Pcs)
Table 37. Global Osimertinib Price by Type (2021-2026) & (USD/Pcs)
Table 38. Global Osimertinib Sales by Application (2016-2021e) & (K Pcs)
Table 39. Global Osimertinib Sales by Application (2021-2026) & (K Pcs)
Table 40. Global Osimertinib Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Osimertinib Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Osimertinib Price by Application (2016-2021e) & (USD/Pcs)
Table 43. Global Osimertinib Price by Application (2021-2026) & (USD/Pcs)
Table 44. North America Osimertinib Sales by Country (2016-2021e) & (K Pcs)
Table 45. North America Osimertinib Sales by Country (2021-2026) & (K Pcs)
Table 46. North America Osimertinib Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Osimertinib Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Osimertinib Sales by Type (2016-2021e) & (K Pcs)
Table 49. North America Osimertinib Sales by Type (2021-2026) & (K Pcs)
Table 50. North America Osimertinib Sales by Application (2016-2021e) & (K Pcs)
Table 51. North America Osimertinib Sales by Application (2021-2026) & (K Pcs)
Table 52. Europe Osimertinib Sales by Country (2016-2021e) & (K Pcs)
Table 53. Europe Osimertinib Sales by Country (2021-2026) & (K Pcs)
Table 54. Europe Osimertinib Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Osimertinib Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Osimertinib Sales by Type (2016-2021e) & (K Pcs)
Table 57. Europe Osimertinib Sales by Type (2021-2026) & (K Pcs)
Table 58. Europe Osimertinib Sales by Application (2016-2021e) & (K Pcs)
Table 59. Europe Osimertinib Sales by Application (2021-2026) & (K Pcs)
Table 60. Asia-Pacific Osimertinib Sales by Region (2016-2021e) & (K Pcs)
Table 61. Asia-Pacific Osimertinib Sales by Region (2021-2026) & (K Pcs)
Table 62. Asia-Pacific Osimertinib Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Osimertinib Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Osimertinib Sales by Type (2016-2021e) & (K Pcs)
Table 65. Asia-Pacific Osimertinib Sales by Type (2021-2026) & (K Pcs)
Table 66. Asia-Pacific Osimertinib Sales by Application (2016-2021e) & (K Pcs)
Table 67. Asia-Pacific Osimertinib Sales by Application (2021-2026) & (K Pcs)
Table 68. South America Osimertinib Sales by Country (2016-2021e) & (K Pcs)
Table 69. South America Osimertinib Sales by Country (2021-2026) & (K Pcs)
Table 70. South America Osimertinib Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Osimertinib Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Osimertinib Sales by Type (2016-2021e) & (K Pcs)
Table 73. South America Osimertinib Sales by Type (2021-2026) & (K Pcs)
Table 74. South America Osimertinib Sales by Application (2016-2021e) & (K Pcs)
Table 75. South America Osimertinib Sales by Application (2021-2026) & (K Pcs)
Table 76. Middle East & Africa Osimertinib Sales by Country (2016-2021e) & (K Pcs)
Table 77. Middle East & Africa Osimertinib Sales by Country (2021-2026) & (K Pcs)
Table 78. Middle East & Africa Osimertinib Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Osimertinib Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Osimertinib Sales by Type (2016-2021e) & (K Pcs)
Table 81. Middle East & Africa Osimertinib Sales by Type (2021-2026) & (K Pcs)
Table 82. Middle East & Africa Osimertinib Sales by Application (2016-2021e) & (K Pcs)
Table 83. Middle East & Africa Osimertinib Sales by Application (2021-2026) & (K Pcs)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Osimertinib Typical Distributors
Table 87. Osimertinib Typical Customers
List of Figures
Figure 1. Osimertinib Picture
Figure 2. Global Osimertinib Sales Market Share by Type in 2020
Figure 3. 40mg*30 Tablets
Figure 4. 80mg*30 Tablets
Figure 5. 40mg*10 Tablets
Figure 6. 80mg*10 Tablets
Figure 7. Global Osimertinib Sales Market Share by Application in 2020
Figure 8. Locally Advanced NSCLC
Figure 9. Metastatic NSCLC
Figure 10. Other
Figure 11. Global Osimertinib Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 12. Global Osimertinib Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Osimertinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Osimertinib Sales (2016-2026) & (K Pcs)
Figure 33. Global Osimertinib Production Capacity (2016-2026) & (K Pcs)
Figure 34. Global Osimertinib Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Osimertinib Market Drivers
Figure 36. Osimertinib Market Restraints
Figure 37. Osimertinib Market Trends
Figure 38. Global Osimertinib Sales Market Share by Manufacturer in 2020
Figure 39. Global Osimertinib Revenue Market Share by Manufacturer in 2020
Figure 40. Osimertinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Osimertinib Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Osimertinib Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Osimertinib Sales Market Share by Region (2016-2026)
Figure 44. Global Osimertinib Revenue Market Share by Region (2016-2026)
Figure 45. North America Osimertinib Revenue (2016-2026) & (USD Million)
Figure 46. Europe Osimertinib Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Osimertinib Revenue (2016-2026) & (USD Million)
Figure 48. South America Osimertinib Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Osimertinib Revenue (2016-2026) & (USD Million)
Figure 50. Global Osimertinib Sales Market Share by Type (2016-2026)
Figure 51. Global Osimertinib Revenue Market Share by Type (2016-2026)
Figure 52. Global Osimertinib Price by Type (2016-2026) & (USD/Pcs)
Figure 53. Global Osimertinib Sales Market Share by Application (2016-2026)
Figure 54. Global Osimertinib Revenue Market Share by Application (2016-2026)
Figure 55. Global Osimertinib Price by Application (2016-2026) & (USD/Pcs)
Figure 56. North America Osimertinib Sales Market Share by Country (2016-2026)
Figure 57. North America Osimertinib Revenue Market Share by Country (2016-2026)
Figure 58. North America Osimertinib Sales Market Share by Type (2016-2026)
Figure 59. North America Osimertinib Sales Market Share by Application (2016-2026)
Figure 60. Europe Osimertinib Sales Market Share by Country (2016-2026)
Figure 61. Europe Osimertinib Revenue Market Share by Country (2016-2026)
Figure 62. Europe Osimertinib Sales Market Share by Type (2016-2026)
Figure 63. Europe Osimertinib Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Osimertinib Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Osimertinib Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Osimertinib Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Osimertinib Sales Market Share by Application (2016-2026)
Figure 68. South America Osimertinib Sales Market Share by Country (2016-2026)
Figure 69. South America Osimertinib Revenue Market Share by Country (2016-2026)
Figure 70. South America Osimertinib Sales Market Share by Type (2016-2026)
Figure 71. South America Osimertinib Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Osimertinib Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Osimertinib Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Osimertinib Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Osimertinib Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のエルトロンボパグ錠市場 2021：企業別、地域別、種類・用途別 The Eltrombopag Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界の食洗機用タブレット市場 2021：企業別、地域別、種類・用途別 The Dishwasher Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のミルタザピン錠市場 2021：企業別、地域別、種類・用途別 The Mirtazapine Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のアモキシシリン分散錠（DT）市場 2021：企業別、地域別、種類・用途別 The Amoxicillin Dispersible Tablets (DT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のハイブリッドタブレット＆ラップトップ市場 2021：企業別、地域別、種類・用途別 The Hybrid Tablets and Laptop market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…